MOVETIS
Movetis NV, a pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company's lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women. Resolor is a... lso tested for chronic constipation in males and children, as well as opioid-induced constipation and post operative ileus. Its products also include M0002, which is in Phase II trials to treat ascites, an accumulation of fluid caused by liver malfunction; and M0003 that is entering Phase II development for symptomatic treatment of heartburn and regurgitation in patient's refractory to PPIs, and pediatric reflux. In addition, the company also has two prioritized compounds out of its preclinical portfolio, M0014 and M0012, and two compound libraries. It has partnership agreements with the universities of Ghent, Leuven, and Rotterdam. The company was founded in 2006 and is headquartered in Turnhout, Belgium.
MOVETIS
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Turnhout, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.movetis.com
Total Employee:
11+
Status:
Active
Contact:
32 1 440 43 90
Total Funding:
63.79 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Novacta Biosystems
Novacta Biosystems develops and markets drugs for the treatment of bacterial infections, especially those caused by drug resistant bacteria.
Current Advisors List
Current Employees Featured
Founder
Investors List
Quest for Growth
Quest for Growth investment in Series A - Movetis
Gimv
Gimv investment in Series A - Movetis
Sofinnova Partners
Sofinnova Partners investment in Series A - Movetis
BIP Investment Partners
BIP Investment Partners investment in Series A - Movetis
Life Sciences Partners
Life Sciences Partners investment in Series A - Movetis
KBC
KBC investment in Series A - Movetis
Sofinnova Investments
Sofinnova Investments investment in Series A - Movetis
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Movetis
Official Site Inspections
http://www.movetis.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109